Patent ID: 11970534
Assignee: STCUBE & CO., INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 7:
8. The method of claim 7, wherein the cancer is selected from the group consisting of lung cancer, prostate cancer, pancreatic cancer, ovarian cancer, liver cancer, head & neck cancer, breast cancer, stomach cancer, carcinoma, lymphoma, blastoma, sarcoma, leukemia, squamous cell cancer, cancer of the peritoneum, hepatocellular cancer, esophageal cancer, glioblastoma, cervical cancer, bladder cancer, colon cancer, colorectal cancer, endometrial or uterine carcinoma, salivary gland carcinoma, kidney or renal cancer, vulvar cancer, thyroid cancer, melanoma, superficial spreading melanoma, lentigo malignant melanoma, acral lentiginous melanomas, nodular melanomas, uveal melanomas, germ cell tumors, as well as B-cell lymphoma, chronic lymphocytic leukemia (CLL), acute lymphoblastic leukemia (ALL), Hairy cell leukemia, multiple myeloma, acute myeloid leukemia (AML) and chronic myeloblastic leukemia.